- Home
- NYC vs VVOS Comparison
NYC vs VVOS Comparison
Compare NYC & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- VVOS
- Stock Information
- Founded
- NYC 2013
- VVOS 2016
- Country
- NYC United States
- VVOS United States
- Employees
- NYC N/A
- VVOS N/A
- Industry
- NYC Real Estate
- VVOS Medical Specialities
- Sector
- NYC Finance
- VVOS Health Care
- Exchange
- NYC Nasdaq
- VVOS Nasdaq
- Market Cap
- NYC 27.6M
- VVOS 22.9M
- IPO Year
- NYC N/A
- VVOS 2020
- Fundamental
- Price
- NYC $10.45
- VVOS $3.12
- Analyst Decision
- NYC
- VVOS Strong Buy
- Analyst Count
- NYC 0
- VVOS 2
- Target Price
- NYC N/A
- VVOS $6.30
- AVG Volume (30 Days)
- NYC 8.2K
- VVOS 164.0K
- Earning Date
- NYC 03-31-2025
- VVOS 03-27-2025
- Dividend Yield
- NYC N/A
- VVOS N/A
- EPS Growth
- NYC N/A
- VVOS N/A
- EPS
- NYC N/A
- VVOS N/A
- Revenue
- NYC $62,060,000.00
- VVOS $14,581,000.00
- Revenue This Year
- NYC N/A
- VVOS $12.35
- Revenue Next Year
- NYC $3.18
- VVOS $26.02
- P/E Ratio
- NYC N/A
- VVOS N/A
- Revenue Growth
- NYC N/A
- VVOS 0.54
- 52 Week Low
- NYC $5.46
- VVOS $1.91
- 52 Week High
- NYC $12.52
- VVOS $6.28
- Technical
- Relative Strength Index (RSI)
- NYC 50.89
- VVOS 32.31
- Support Level
- NYC $10.50
- VVOS $3.75
- Resistance Level
- NYC $12.52
- VVOS $4.27
- Average True Range (ATR)
- NYC 0.68
- VVOS 0.35
- MACD
- NYC -0.04
- VVOS -0.10
- Stochastic Oscillator
- NYC 22.18
- VVOS 8.73
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.